2 studies found for:    21353695 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
Condition: Bone Metastases
Interventions: Drug: zoledronic acid;   Biological: denosumab
2 Recruiting Radiotherapy for Oligometastatic Prostate Cancer
Condition: Oligometastatic Prostate Cancer
Intervention: Radiation: SBRT/SHRT

Indicates status has not been verified in more than two years